Bayesian semi-supervised learning for uncertainty-calibrated prediction of molecular properties and active learning.

Representation
DOI: 10.17863/cam.48436 Publication Date: 2019-07-10
ABSTRACT
Predicting bioactivity and physical properties of small molecules is a central challenge in drug discovery. Deep learning becoming the method choice but studies to date focus on mean accuracy as main metric. However, replace costly mission-critical experiments by models, high not enough: outliers can derail discovery campaign, thus models need reliably predict when it will fail, even training data biased; are expensive, be data-efficient suggest informative sets using active learning. We show that uncertainty quantification achieved Bayesian semi-supervised graph convolutional neural networks. The approach estimates statistically principled way through sampling from posterior distribution. Semi-supervised disentangles representation regression, keeping accurate low limit allowing model start initial pool data. Our study highlights promise deep for chemistry.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....